menu search

Unpacking infinera's performance and prospects: is it time to buy?

Infinera is a significant player in modern communication technology, providing advanced networking solutions to a diverse clientele. The company's str...

October 3, 2023, 6:50 am

Gbp to usd forecast: deteriorating macro view dims pound prospects

Amidst UK economic struggles, the GBP/USD pair encounters pressure, signaling caution as the Pound braces for ...

October 3, 2023, 6:17 am

Not much relief, after all

Relief that came with the news of a temporary avoidance of a potential government shutdown remained sho...

October 3, 2023, 5:58 am

Bel fuse: great long-term potential, inexpensive valuation, but beware of the china risk

Bel Fuse is massively undervalued relative to its peers on an EV/EBIT basis, despite being a high-quality company. The company is focused on growth in...

October 3, 2023, 5:34 am

Technical outlook and review

DXY: The DXY chart currently demonstrates a bullish momentum, with the possibility of a short-term drop to the 1st support level before...

October 3, 2023, 5:28 am

Wework intends to skip bond interest payments, despite available liquidity

WeWork Inc (NYSE:WE) has elected to withhold interest payments on five of its bonds, initiating a 30-day grace period before a...

October 3, 2023, 4:06 am

Cadence bank - strong loan growth and depressed valuation make for a buy

Cadence Bank offers a solid investment opportunity with strong loan growth and potential for higher ear...

October 3, 2023, 4:04 am

Usdcad analysis – october 3, 2023

USD/CAD has successfully broken above the resistance level at 1.3694, indicating a potential further ri...

October 3, 2023, 3:00 am

Editas medicine: ruby gems, sparkling catalysts in sickle cell arena

Editas Medicine's reduced R&D costs and strong cash position provide operational comfort but necessitate future capital, especially amid looming compe...

October 3, 2023, 2:59 am

Brandywine: one in the hand, two in the bush

Brandywine owns and manages a portfolio of office, life science/lab, residential, and mixed-use properties. The dividend yield is not safe but also un...

October 3, 2023, 2:26 am

Verona pharma to present additional analyses of positive phase 3 enhance studies in copd at chest 2023

PDUFA Target Action Date of June 26, 2024 Pooled analysis and subgroup data further support potential o...

October 3, 2023, 2:00 am

Diversifying commodities rise 16% in q3 2023 as equities drop

This highlighted the potential diversification qualities of this asset class, as equities and fixed inc...

October 3, 2023, 1:59 am

Bragar eagel & squire, p.c. is investigating orthofix, and scynexis and encourages investors to contact the firm

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating...

October 3, 2023, 1:00 am

Bragar eagel & squire, p.c. is investigating xponential, bowlero, and advance auto parts and encourages investors to contact the firm

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating...

October 3, 2023, 1:00 am

Bragar eagel & squire, p.c. is investigating fmc, veradigm, and blink and encourages investors to contact the firm

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating...

October 3, 2023, 1:00 am

Bp: significantly undervalued at current oil prices

BP has experienced challenging conditions in the oil market but has financially stabilized and is now a cash cow. The company plans to give back surpl...

October 3, 2023, 12:24 am

Lloyds banking: capital returns potential remains compelling

Lloyds shares have been disappointingly flat since I first covered the bank last year, with general UK apathy, FX and recession worries weighing on th...

October 2, 2023, 11:45 pm

Newamsterdam pharma's pioneering pulse on alzheimer's breakthroughs

New clinical data shows the potential of obicetrapib in treating early Alzheimer's disease in patients ...

October 2, 2023, 9:26 pm

Workiva: leveraging competitive advantage in a regulatory-focused landscape

Workiva's platform is a leading cloud platform for integrated reporting, streamlining processes, and ensuring transparency. The company's strong finan...

October 2, 2023, 9:01 pm

Galiano gold: production increase and excellent growth potential

Galiano Gold operates and manages the Asanko gold mine, or AGM, and it owns the Asumura project. Find out my recommended buying range for GAU stock. R...

October 2, 2023, 7:44 pm


Search within

Pages Search Results: